Hva kan vi forvente fre disse to presentasjonene ?
Published: 07:00 CET 14-11-2017 /GlobeNewswire /Source: Targovax ASA / : TRVX /ISIN: NO0010689326
Targovax to present at upcoming investor conferences
Oslo, Norway, 14 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present at the following life sciences and investor conferences:
Date: 14 November 2017
Venue: The Nordic-American Life Science Conference, NYC, USA
Presentation time: 10:25 EST
Presenter: Erik Digman Wiklund (CFO)
Date: 5 December 2017
Venue: Carnegie Nordic Healthcare day, NYC, USA
Presenter: Øystein Soug (CEO)
Targovax to present at upcoming investor conferences
Oslo, Norway, 14 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present at the following life sciences and investor conferences:
Date: 14 November 2017
Venue: The Nordic-American Life Science Conference, NYC, USA
Presentation time: 10:25 EST
Presenter: Erik Digman Wiklund (CFO)
Date: 5 December 2017
Venue: Carnegie Nordic Healthcare day, NYC, USA
Presenter: Øystein Soug (CEO)
Redigert 20.01.2021 kl 08:37
Du må logge inn for å svare
OstoreOrakel
14.11.2017 kl 09:31
2137
Jeg har forventninger om readouts i forbindelse med presentasjonen 5 desember :)